QKBGX
Price
$23.64
Change
+$0.05 (+0.21%)
Updated
Oct 17 closing price
Net Assets
299.61M
RLBEX
Price
$38.94
Change
+$0.04 (+0.10%)
Updated
Oct 17 closing price
Net Assets
265.62B
Interact to see
Advertisement

QKBGX vs RLBEX

Header iconQKBGX vs RLBEX Comparison
Open Charts QKBGX vs RLBEXBanner chart's image
Federated Hermes MDT Balanced R6
Price$23.64
Change+$0.05 (+0.21%)
VolumeN/A
Net Assets299.61M
American Funds American Balanced R4
Price$38.94
Change+$0.04 (+0.10%)
VolumeN/A
Net Assets265.62B
QKBGX vs RLBEX Comparison Chart in %
View a ticker or compare two or three
VS
QKBGX vs. RLBEX commentary
Oct 20, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is QKBGX is a Hold and RLBEX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RLBEX has more cash in the bank: 266B vs. QKBGX (300M). RLBEX pays higher dividends than QKBGX: RLBEX (1.74) vs QKBGX (1.43). QKBGX was incepted earlier than RLBEX: QKBGX (19 years) vs RLBEX (23 years). QKBGX (1.05) is less costly to investors than RLBEX (0.59). QKBGX is a more actively managed with annual turnover of: 68.00 vs. RLBEX (44.00). QKBGX has a lower initial minimum investment than RLBEX: QKBGX (0) vs RLBEX (250). RLBEX annual gain was more profitable for investors over the last year : 8.70 vs. QKBGX (2.30). RLBEX return over 5 years is better than : 42.04 vs. QKBGX (24.45).
QKBGXRLBEXQKBGX / RLBEX
Total Expense Ratio1.050.59178%
Annual Report Gross Expense Ratio1.050.59178%
Fund Existence19 years23 years-
Gain YTD11.40414.63178%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets300M266B0%
Annual Yield % from dividends1.431.7482%
Returns for 1 year2.308.7026%
Returns for 3 years34.9850.5269%
Returns for 5 years24.4542.0458%
Returns for 10 years61.7977.6980%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
COEP15.380.38
+2.53%
Coeptis Therapeutics Holdings Inc
DHT12.110.23
+1.94%
DHT Holdings
PTLO5.900.02
+0.34%
Portillo's
ATMVU22.00N/A
N/A
AlphaVest Acquisition Corp
BBIO54.92-0.11
-0.20%
BridgeBio Pharma